2024 Q4 Form 10-Q Financial Statement

#000142146124000032 Filed on November 05, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $57.55M
YoY Change 5.59%
Cost Of Revenue $49.82M
YoY Change -7.75%
Gross Profit $7.732M
YoY Change 1474.75%
Gross Profit Margin 13.44%
Selling, General & Admin $9.154M
YoY Change 19.12%
% of Gross Profit 118.39%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.115M
YoY Change -10.65%
% of Gross Profit 117.89%
Operating Expenses $9.154M
YoY Change 19.12%
Operating Profit -$2.223M
YoY Change -75.75%
Interest Expense $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $136.0K
YoY Change 615.79%
Pretax Income -$1.840M
YoY Change -79.81%
Income Tax -$7.000K
% Of Pretax Income
Net Earnings -$1.833M
YoY Change -74.53%
Net Earnings / Revenue -3.19%
Basic Earnings Per Share -$0.14
Diluted Earnings Per Share -$0.14
COMMON SHARES
Basic Shares Outstanding 13.16M shares 13.28M shares
Diluted Shares Outstanding 12.91M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $40.01M
YoY Change 535.13%
Cash & Equivalents $38.03M
Short-Term Investments $1.979M
Other Short-Term Assets $5.783M
YoY Change 5.15%
Inventory $109.6M
Prepaid Expenses
Receivables $32.22M
Other Receivables $2.659M
Total Short-Term Assets $190.3M
YoY Change 29.77%
LONG-TERM ASSETS
Property, Plant & Equipment $354.9M
YoY Change -11.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $4.699M
YoY Change -40.52%
Other Assets $9.395M
YoY Change 36.87%
Total Long-Term Assets $616.0M
YoY Change -4.68%
TOTAL ASSETS
Total Short-Term Assets $190.3M
Total Long-Term Assets $616.0M
Total Assets $806.2M
YoY Change 1.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.917M
YoY Change 1.33%
Accrued Expenses $14.73M
YoY Change 1.45%
Deferred Revenue $1.000M
YoY Change 0.0%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $43.19M
YoY Change 13.07%
LONG-TERM LIABILITIES
Long-Term Debt $2.082M
YoY Change -43.73%
Other Long-Term Liabilities $1.502M
YoY Change 23.01%
Total Long-Term Liabilities $1.502M
YoY Change 23.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $43.19M
Total Long-Term Liabilities $1.502M
Total Liabilities $125.6M
YoY Change 73.6%
SHAREHOLDERS EQUITY
Retained Earnings $34.99M
YoY Change -55.18%
Common Stock $667.6M
YoY Change 0.49%
Preferred Stock
YoY Change
Treasury Stock (at cost) $22.01M
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity $680.6M
YoY Change
Total Liabilities & Shareholders Equity $806.2M
YoY Change 1.69%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$1.833M
YoY Change -74.53%
Depreciation, Depletion And Amortization $9.115M
YoY Change -10.65%
Cash From Operating Activities -$4.342M
YoY Change 1347.33%
INVESTING ACTIVITIES
Capital Expenditures $9.609M
YoY Change -42.11%
Acquisitions
YoY Change
Other Investing Activities $505.0K
YoY Change -27.86%
Cash From Investing Activities -$9.104M
YoY Change -42.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -180.0K
YoY Change -110.0%
NET CHANGE
Cash From Operating Activities -4.342M
Cash From Investing Activities -9.104M
Cash From Financing Activities -180.0K
Net Change In Cash -13.63M
YoY Change -4.71%
FREE CASH FLOW
Cash From Operating Activities -$4.342M
Capital Expenditures $9.609M
Free Cash Flow -$13.95M
YoY Change -17.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13163221 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38034000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4071000 usd
CY2024Q3 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
1979000 usd
CY2023Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
2970000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
32223000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22077000 usd
CY2024Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
2659000 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1470000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
109578000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
114252000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5783000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7200000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
190256000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
152040000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
354898000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
358249000 usd
CY2024Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
19184000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
19184000 usd
CY2024Q3 ipi Long Term Parts Inventory Noncurrent
LongTermPartsInventoryNoncurrent
32385000 usd
CY2023Q4 ipi Long Term Parts Inventory Noncurrent
LongTermPartsInventoryNoncurrent
30231000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
194223000 usd
CY2024Q3 us-gaap Assets
Assets
806219000 usd
CY2023Q4 us-gaap Assets
Assets
768570000 usd
CY2024Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
8917000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1833000 usd
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001421461
dei Amendment Flag
AmendmentFlag
false
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
195402000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11810000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7254000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7730000 usd
CY2024Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
0 usd
CY2023Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
4000000 usd
CY2023Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
30077000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
855000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
741000 usd
CY2024Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
2082000 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1451000 usd
CY2024Q3 us-gaap Inventory Write Down
InventoryWriteDown
471000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
7732000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
491000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9154000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7685000 usd
CY2024Q3 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
623000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5071000 usd
us-gaap Inventory Write Down
InventoryWriteDown
2326000 usd
us-gaap Inventory Write Down
InventoryWriteDown
3413000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-626000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-252000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
110000 usd
ipi Reserve For Obsolescence
ReserveForObsolescence
643000 usd
ipi Reserve For Obsolescence
ReserveForObsolescence
140000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38621000 usd
CY2023Q3 ipi Incremental Common Shares Attributable To Restricted Stock
IncrementalCommonSharesAttributableToRestrictedStock
0 shares
ipi Incremental Common Shares Attributable To Restricted Stock
IncrementalCommonSharesAttributableToRestrictedStock
0 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-7196000 usd
us-gaap Net Income Loss
NetIncomeLoss
1615000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12789000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12871000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12750000 shares
CY2023Q3 ipi Incremental Common Shares Attributable To Stock Options
IncrementalCommonSharesAttributableToStockOptions
0 shares
ipi Incremental Common Shares Attributable To Stock Options
IncrementalCommonSharesAttributableToStockOptions
0 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12789000 shares
CY2024Q3 us-gaap Depreciation
Depreciation
8013000 usd
us-gaap Depletion
Depletion
1968000 usd
CY2024Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
316000 usd
CY2023Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
399000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
1022000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
1181000 usd
CY2024Q3 ipi Depreciation Depletion And Amortization Excluding Intangible Assets
DepreciationDepletionAndAmortizationExcludingIntangibleAssets
9033000 usd
CY2023Q3 ipi Depreciation Depletion And Amortization Excluding Intangible Assets
DepreciationDepletionAndAmortizationExcludingIntangibleAssets
10122000 usd
ipi Depreciation Depletion And Amortization Excluding Intangible Assets
DepreciationDepletionAndAmortizationExcludingIntangibleAssets
26931000 usd
ipi Depreciation Depletion And Amortization Excluding Intangible Assets
DepreciationDepletionAndAmortizationExcludingIntangibleAssets
28305000 usd
CY2024Q3 us-gaap Interest Costs Incurred
InterestCostsIncurred
200000 usd
us-gaap Interest Costs Incurred
InterestCostsIncurred
500000 usd
CY2023Q3 us-gaap Interest Costs Incurred
InterestCostsIncurred
200000 usd
CY2023Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
27934000 usd
CY2023Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
30359000 usd
CY2024Q3 us-gaap Inventory Write Down
InventoryWriteDown
471000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
7732000 usd
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9115000 usd
dei Entity File Number
EntityFileNumber
001-34025
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
1605000 usd
dei Entity Registrant Name
EntityRegistrantName
INTREPID POTASH, INC.
dei City Area Code
CityAreaCode
303
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
806219000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
768570000 usd
CY2024Q3 us-gaap Long Term Investments
LongTermInvestments
4699000 usd
CY2024Q3 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
46053000 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12908078 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12807316 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
14000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
13000 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
667597000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
665637000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
34994000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
40790000 usd
CY2024Q3 us-gaap Treasury Stock Value
TreasuryStockValue
22012000 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
22012000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
680593000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
684428000 usd
CY2023Q3 us-gaap Inventory Write Down
InventoryWriteDown
3413000 usd
us-gaap Inventory Write Down
InventoryWriteDown
2326000 usd
us-gaap Inventory Write Down
InventoryWriteDown
3413000 usd
us-gaap Gross Profit
GrossProfit
21790000 usd
us-gaap Gross Profit
GrossProfit
32225000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7685000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
25448000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24491000 usd
CY2023Q3 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
535000 usd
CY2023Q3 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
535000 usd
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
1867000 usd
CY2024Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
874000 usd
CY2023Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
521000 usd
CY2023Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
521000 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
3082000 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
521000 usd
CY2024Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-134000 usd
CY2023Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-59000 usd
CY2023Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-59000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-626000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-252000 usd
CY2024Q3 us-gaap Other Nonrecurring Income
OtherNonrecurringIncome
1370000 usd
CY2023Q3 us-gaap Other Nonrecurring Income
OtherNonrecurringIncome
522000 usd
us-gaap Other Nonrecurring Income
OtherNonrecurringIncome
4029000 usd
us-gaap Other Nonrecurring Income
OtherNonrecurringIncome
1252000 usd
CY2024Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
540000 usd
CY2023Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1379000 usd
CY2023Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1379000 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
2953000 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
3132000 usd
CY2024Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-289000 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-54000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-256000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-292000 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
536000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
88000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1327000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
249000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
136000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
19000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
204000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
75000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1840000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9113000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6882000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3508000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1917000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1086000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1893000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1833000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-7196000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5796000 usd
us-gaap Net Income Loss
NetIncomeLoss
1615000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12908000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12789000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12750000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12908000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12789000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12871000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12876000 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
ipi Incremental Common Shares Attributable To Stock Options
IncrementalCommonSharesAttributableToStockOptions
46000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12876000 shares
us-gaap Interest Costs Incurred
InterestCostsIncurred
500000 usd
us-gaap Line Of Credit Facility Commitment Fee Amount
LineOfCreditFacilityCommitmentFeeAmount
169000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
226000 usd
us-gaap Interest Costs Incurred
InterestCostsIncurred
528000 usd
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
528000 usd
us-gaap Interest Expense
InterestExpense
0 usd
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
1605000 usd
CY2023Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
28169000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2374000 usd
ipi Contract With Customer Payment Received Performance Obligation Not Yet Satisfied
ContractWithCustomerPaymentReceivedPerformanceObligationNotYetSatisfied
627000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
811000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2190000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2700000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5100000 usd
CY2024Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
58000 usd
CY2023Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
3000 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
93000 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
137000 usd
CY2024Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-65000 usd
CY2023Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1920000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1179000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1917000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1086000 usd
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.004
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.158
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.210
CY2024Q3 ipi Reclamation Deposits And Surety Bonds
ReclamationDepositsAndSuretyBonds
27100000 usd
CY2024Q3 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
2300000 usd
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
1500000 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1501877
dei Entity Address Address Line1
EntityAddressAddressLine1
707 17th Street, Suite 4200
dei Entity Address City Or Town
EntityAddressCityOrTown
Denver,
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80202
dei Local Phone Number
LocalPhoneNumber
296-3006
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
IPI
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
6627000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9395000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8016000 usd
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
12848000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14733000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14061000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
12401000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
43190000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
46564000 usd
CY2024Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
31944000 usd
CY2023Q4 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
0 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1502000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1309000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
125626000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
84142000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2223000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9166000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-8157000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
3476000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12871000 shares
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
684428000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5796000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2735000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
774000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
680593000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
682248000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
178000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
680593000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
715078000 usd
us-gaap Net Income Loss
NetIncomeLoss
1615000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5071000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1337000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
720427000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
726101000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-7196000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1522000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
720427000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5796000 usd
us-gaap Net Income Loss
NetIncomeLoss
1615000 usd
ipi Depreciation Depletion And Amortization Excluding Intangible Assets
DepreciationDepletionAndAmortizationExcludingIntangibleAssets
26931000 usd
ipi Depreciation Depletion And Amortization Excluding Intangible Assets
DepreciationDepletionAndAmortizationExcludingIntangibleAssets
28305000 usd
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
1867000 usd
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
1605000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
226000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
226000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
246000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
241000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2735000 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
3082000 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
521000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-101000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-256000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-292000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
0 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
452000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10146000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2536000 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1245000 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1659000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
448000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2379000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
226000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
898000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1179000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1756000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4009000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5216000 usd
ipi Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1074000 usd
ipi Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1218000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
43308000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1306000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1298000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
64936000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
38625000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
32583000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
58484000 usd
us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
0 usd
us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
1415000 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
4656000 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
125000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
2000000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
4500000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-416000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-668000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25511000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-54606000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
7000000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
4000000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
5000000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
680000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
399000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
775000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1337000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5455000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
264000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
33970000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15717000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4651000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19084000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3367000 usd
us-gaap Interest Paid Net
InterestPaidNet
382000 usd
us-gaap Interest Paid Net
InterestPaidNet
287000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
295000 usd
ipi Amounts Included In The Measurement Of Operating Lease Liabilities
AmountsIncludedInTheMeasurementOfOperatingLeaseLiabilities
1143000 usd
ipi Amounts Included In The Measurement Of Operating Lease Liabilities
AmountsIncludedInTheMeasurementOfOperatingLeaseLiabilities
1357000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1868000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3241000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
751000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
48000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
1562000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
3009000 usd
us-gaap Nature Of Operations
NatureOfOperations
COMPANY BACKGROUND<div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a diversified mineral company that delivers potassium, magnesium, sulfur, salt, and water products essential for customer success in agriculture, animal feed, and the oil and gas industry. We are the only U.S. producer of muriate of potash (sometimes referred to as potassium chloride or potash), which is applied as an essential nutrient for healthy crop development, utilized in several industrial applications, and used as an ingredient in animal feed. In addition, we produce a specialty fertilizer, Trio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which delivers three key nutrients, potassium, magnesium, and sulfate, in a single particle. We also provide water, salt, magnesium chloride, brine, and various oilfield products and services.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our extraction and production operations are conducted entirely in the continental U.S. We produce potash from three solution mining facilities: our HB solution mine in Carlsbad, New Mexico, our solution mine in Moab, Utah, and our brine recovery mine in Wendover, Utah. We also operate the North compaction facility in Carlsbad, New Mexico, which compacts and granulates product from the HB mine. We produce Trio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> from our conventional underground East mine in Carlsbad, New Mexico.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    We have permitted, licensed, declared, and partially adjudicated water rights in New Mexico that support our mining and industrial operations. Water that is not used to support our mining and industrial operations is primarily sold to support oil and gas development in the Permian Basin in New Mexico near our Carlsbad facilities. We continue to work to expand our water business. See Note 15—Commitments and Contingencies below for further information regarding our water rights.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also operate certain land, water rights, grazing leases, and other related assets in southeast New Mexico. We refer to these assets and operations as "Intrepid South." Due to the strategic location of Intrepid South, part of our long-term operating strategy is selling small parcels of land, including restricted use agreements of surface or subsurface rights, to customers where such sales provide a solution to such customer's operations in the oil and gas industry. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have three segments: potash, Trio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and oilfield solutions. We account for sales of byproducts as revenue in the potash or Trio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> segment based on which segment generates the byproduct. Intersegment sales prices are market based and are eliminated.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"Intrepid," "our," "we," or "us" means Intrepid Potash, Inc. and its consolidated subsidiaries.</span></div>
ipi Number Of Key Nutrients
NumberOfKeyNutrients
3 nutrient
ipi Number Of Mining Facilities
NumberOfMiningFacilities
3 facility
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Certain prior period amounts have been reclassified in order to conform to the current period presentation. These reclassifications had no effect on the reported results of operations.
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1833000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5796000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12908000 shares
CY2024Q3 ipi Incremental Common Shares Attributable To Restricted Stock
IncrementalCommonSharesAttributableToRestrictedStock
0 shares
ipi Incremental Common Shares Attributable To Restricted Stock
IncrementalCommonSharesAttributableToRestrictedStock
80000 shares
CY2024Q3 ipi Incremental Common Shares Attributable To Stock Options
IncrementalCommonSharesAttributableToStockOptions
0 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12908000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12871000 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38034000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2791000 usd
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
25000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
25000 usd
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
562000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
551000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38621000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3367000 usd
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
53734000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
66033000 usd
CY2024Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
35135000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
28044000 usd
CY2024Q3 us-gaap Inventory Finished Goods And Work In Process Net Of Reserves
InventoryFinishedGoodsAndWorkInProcessNetOfReserves
88869000 usd
CY2023Q4 us-gaap Inventory Finished Goods And Work In Process Net Of Reserves
InventoryFinishedGoodsAndWorkInProcessNetOfReserves
94077000 usd
CY2024Q3 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
20709000 usd
CY2023Q4 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
20175000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
109578000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
114252000 usd
CY2024Q3 ipi Long Term Parts Inventory Noncurrent
LongTermPartsInventoryNoncurrent
32385000 usd
CY2023Q4 ipi Long Term Parts Inventory Noncurrent
LongTermPartsInventoryNoncurrent
30231000 usd
CY2024Q3 ipi Inventory Current And Noncurrent Net
InventoryCurrentAndNoncurrentNet
141963000 usd
CY2023Q4 ipi Inventory Current And Noncurrent Net
InventoryCurrentAndNoncurrentNet
144483000 usd
CY2024Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
200000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
900000 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
729365000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
709901000 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
374467000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
351652000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
354898000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
358249000 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
3100000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
9102000 usd
us-gaap Depreciation
Depreciation
23072000 usd
us-gaap Depreciation
Depreciation
25156000 usd
CY2024Q3 us-gaap Depletion
Depletion
704000 usd
CY2023Q3 us-gaap Depletion
Depletion
621000 usd
us-gaap Depletion
Depletion
2837000 usd
CY2024Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
53000 usd
CY2023Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
58000 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
134000 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
133000 usd
CY2024Q3 us-gaap Line Of Credit Facility Commitment Fee Amount
LineOfCreditFacilityCommitmentFeeAmount
57000 usd
CY2023Q3 us-gaap Line Of Credit Facility Commitment Fee Amount
LineOfCreditFacilityCommitmentFeeAmount
57000 usd
us-gaap Line Of Credit Facility Commitment Fee Amount
LineOfCreditFacilityCommitmentFeeAmount
171000 usd
CY2024Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
75000 usd
CY2023Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
75000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
226000 usd
CY2024Q3 us-gaap Interest Costs Incurred
InterestCostsIncurred
185000 usd
CY2023Q3 us-gaap Interest Costs Incurred
InterestCostsIncurred
190000 usd
us-gaap Interest Costs Incurred
InterestCostsIncurred
531000 usd
CY2024Q3 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
185000 usd
CY2023Q3 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
190000 usd
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
531000 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
0 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
0 usd
us-gaap Interest Expense
InterestExpense
0 usd
CY2024Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
19200000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
19200000 usd
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P14Y9M18D
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4900000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4900000 usd
CY2024Q3 us-gaap Cash
Cash
38000000.0 usd
CY2023Q4 us-gaap Cash
Cash
4100000 usd
CY2024Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
31603000 usd
CY2022Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
26864000 usd
CY2024Q3 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
623000 usd
CY2023Q3 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
535000 usd
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
1867000 usd
CY2024Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
32226000 usd
CY2023Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
28469000 usd
CY2024Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
32226000 usd
CY2023Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
28469000 usd
CY2024Q3 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
282000 usd
CY2023Q3 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
300000 usd
CY2024Q3 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
282000 usd
CY2023Q3 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
300000 usd
CY2024Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
31944000 usd
CY2023Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
28169000 usd
CY2024Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
31944000 usd
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2500000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2300000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1000000.0 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1000000.0 usd
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2857000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2168000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2303000 usd
CY2024Q3 ipi Contract With Customer Payment Received Performance Obligation Not Yet Satisfied
ContractWithCustomerPaymentReceivedPerformanceObligationNotYetSatisfied
27000 usd
CY2023Q3 ipi Contract With Customer Payment Received Performance Obligation Not Yet Satisfied
ContractWithCustomerPaymentReceivedPerformanceObligationNotYetSatisfied
313000 usd
ipi Contract With Customer Payment Received Performance Obligation Not Yet Satisfied
ContractWithCustomerPaymentReceivedPerformanceObligationNotYetSatisfied
1324000 usd
CY2024Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
419000 usd
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
291000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1162000 usd
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2465000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2190000 usd
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2465000 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1000000.0 shares
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
200000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1500000 usd
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
4000000.0 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y4M24D
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1756000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1893000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.540
CY2023Q4 ipi Reclamation Deposits And Surety Bonds
ReclamationDepositsAndSuretyBonds
26800000 usd
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
500000 usd
CY2024Q3 ipi Surety Bonds
SuretyBonds
26600000 usd
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
500000 usd
CY2023Q4 ipi Surety Bonds
SuretyBonds
26300000 usd
CY2023Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
3400000 usd
us-gaap Loss Contingency Accrual Payments
LossContingencyAccrualPayments
1900000 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
500000 usd
CY2024Q3 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
1979000 usd
CY2024Q3 ipi Held To Maturity Securities Accumulated Unrecognized Holding Gain Short Term
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGainShortTerm
0 usd
CY2024Q3 ipi Held To Maturity Securities Accumulated Unrecognized Holding Loss Short Term
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLossShortTerm
1000 usd
CY2024Q3 us-gaap Debt Securities Held To Maturity Fair Value Current
DebtSecuritiesHeldToMaturityFairValueCurrent
1978000 usd
CY2023Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
2970000 usd
CY2023Q4 ipi Held To Maturity Securities Accumulated Unrecognized Holding Gain Short Term
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGainShortTerm
0 usd
CY2023Q4 ipi Held To Maturity Securities Accumulated Unrecognized Holding Loss Short Term
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLossShortTerm
22000 usd
CY2023Q4 us-gaap Debt Securities Held To Maturity Fair Value Current
DebtSecuritiesHeldToMaturityFairValueCurrent
2948000 usd
CY2023Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
954000 usd
CY2023Q4 ipi Held To Maturity Securities Accumulated Unrecognized Holding Gain Long Term
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGainLongTerm
1000 usd
CY2023Q4 ipi Held To Maturity Securities Accumulated Unrecognized Holding Loss Long Term
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLossLongTerm
4000 usd
CY2023Q4 us-gaap Debt Securities Held To Maturity Fair Value Noncurrent
DebtSecuritiesHeldToMaturityFairValueNoncurrent
951000 usd
CY2024Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
2000000.0 usd
CY2023Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
3900000 usd
CY2024Q3 ipi Debt Securities Held To Maturity Maturity Period
DebtSecuritiesHeldToMaturityMaturityPeriod
P1Y
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
us-gaap Inventory Write Down
InventoryWriteDown
2326000 usd
us-gaap Gross Profit
GrossProfit
21790000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
27177000 usd
CY2023Q3 us-gaap Inventory Write Down
InventoryWriteDown
3413000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
491000 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10202000 usd
us-gaap Inventory Write Down
InventoryWriteDown
3413000 usd
us-gaap Gross Profit
GrossProfit
32225000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
28546000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
7732000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
491000 usd
us-gaap Gross Profit
GrossProfit
21790000 usd
us-gaap Gross Profit
GrossProfit
32225000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9154000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7685000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7685000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
25448000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24491000 usd
CY2024Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
874000 usd
CY2023Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
521000 usd
CY2023Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
521000 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
3082000 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
521000 usd
CY2024Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-134000 usd
CY2023Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-59000 usd
CY2023Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-59000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-626000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-252000 usd
CY2024Q3 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
623000 usd
CY2023Q3 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
535000 usd
CY2023Q3 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
535000 usd
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
1867000 usd
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
1605000 usd
CY2024Q3 us-gaap Other Nonrecurring Income
OtherNonrecurringIncome
1370000 usd
CY2023Q3 us-gaap Other Nonrecurring Income
OtherNonrecurringIncome
522000 usd
us-gaap Other Nonrecurring Income
OtherNonrecurringIncome
4029000 usd
us-gaap Other Nonrecurring Income
OtherNonrecurringIncome
1252000 usd
CY2024Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
540000 usd
CY2023Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1379000 usd
CY2023Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1379000 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
2953000 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
3132000 usd
CY2024Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-289000 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-54000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-256000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-292000 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
536000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
88000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1327000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
249000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
136000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
19000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
204000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
75000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1840000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9113000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6882000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3508000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.540
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1200000 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
ipi-20240930_cal.xml Edgar Link unprocessable
ipi-20240930_lab.xml Edgar Link unprocessable
0001421461-24-000032-index-headers.html Edgar Link pending
0001421461-24-000032-index.html Edgar Link pending
0001421461-24-000032.txt Edgar Link pending
0001421461-24-000032-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ipi-09302024xexhibit311.htm Edgar Link pending
ipi-09302024xexhibit321.htm Edgar Link pending
ipi-09302024xexhibit951.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ipi-20240930.htm Edgar Link pending
ipi-20240930.xsd Edgar Link pending
ipi-20240930_g1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
ipi-20240930_def.xml Edgar Link unprocessable
ipi-20240930_pre.xml Edgar Link unprocessable
ipi-20240930_htm.xml Edgar Link completed
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending